Bioniz

Bioniz

Verified
Biotechnology company focused on discovering small peptides and molecules for the treatment of autoimmune diseases and cancer

Launch date
Employees
Firm valuation
$329m (Dealroom.co estimates Feb 2022.)
Irvine Industrial Complex-East United States (HQ)
  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
$599kSeed
N/A$718kSeed
Not yet verified
$13mSeries A
N/AAcquisition
*
$329m
Valuation: $329m
Acquisition
Total Funding$13.6m

Recent News about Bioniz

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.